Talk:MEK inhibitor

Sensitises cancers to immunotherapy
Anti–PD-L1 Immunotherapy, MEK Inhibition Active in Metastatic CRC says "... previous studies have suggested that MEK inhibition could make a tumor more responsive to immunotherapy." - Could find some RS to add this. - Rod57 (talk) 20:02, 5 July 2016 (UTC)